-
Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya
-
Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study
-
Tuberculosis after Preventive Therapy in Persons Living with HIV Initiating Antiretroviral Therapy
-
Tuberculosis after Preventive Therapy in Persons Living with HIV Initiating Antiretroviral Therapy (Response)
-
Determining Etiology of Elephantiasis and Associated Factors in Hawella Tula, Sidama Region, Ethiopia
-
Prevalence, Drug Resistance Patterns, and Associated Factors of Extended-Spectrum Beta-Lactamase–Producing Enterobacterales Among Food Handlers in Student Cafeterias at Arba Minch University, Southern Ethiopia
-
Emergence of Marburg virus disease in Ethiopia: Implications for public health preparedness and its impact on Ethiopia’s health system
-
HIV-1 Genetic Diversity and Drug Resistance Mutations Among Patients on Antiretroviral Therapy in Nairobi County, Kenya
-
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study
-
Overcoming doramectin failure: field efficacy of pour-on 5% fluralaner and an experimental 1% oral formulation for the prevention of –associated umbilical myiasis in newborn calves
-
Conservative Management of Breast Implant–Associated Infections: Identifying Risk Factors for Failure
-
Multivariate predictive model for predicting in-hospital mortality in HIV-associated talaromycosis: a multicenter retrospective study
-
The Burden and Risk Factors of Helicobacter Pylori Infection Among Government Employees Who Clinically Complain of Indigestion but Allergic Diseases in Southeastern Ethiopia: A Multi-Institution Cross-Sectional Study
-
“Effect of Non-Nucleoside Resistance Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights from the Real-World RELATIVITY Cohort”
-
Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor–Based Therapy in Naïve Adults With HIV
-
Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort
-
Adult RSV Vaccination: What Is the Role of RSV Subgroup in Disease Prevention?
-
Serological and molecular positivity for in dogs referred to two veterinary hospitals in Barcelona, Spain
-
HHV8-Associated Multicentric Castleman Disease: A Case Report on a Rare Complication of HIV in a Low-Income Setting
-
Kaposi Sarcoma-Associated Immune Reconstitution Inflammatory Syndrome (KS-IRIS) in Advanced HIV: Challenges in Managing Visceral Disease with Pericardial Involvement
-
Detection of blaOXA-23–Positive Proteus mirabilis Isolate, United States, 2024
-
Clinical Determinants Associated With Viral Load Count Among Adult TB/HIV Co-Infected Patients: A Linear Mixed-Effects Model Analysis
-
Seroprevalence and Risk Factors for Toxoplasma gondii Infection in People Living with HIV: A Cross-Sectional Study from Maputo Central Hospital, Mozambique
-
Infections in Burn Patients: Pathophysiology, Prevention, and Contemporary Therapeutic Strategies in the Era of Antimicrobial Resistance
